Biomarker response on exposure to sunitinib and its primary metabolite (SU12662) in metastatic colorectal cancer patients. 1. Juni 2011 Kanefendt, F., Lindauer, A., Kinzig, M., Strumberg, D., Scheulen, M.E., Mross, K., Fischer, R., Moritz, B., Sörgel, F., Jaehde, U., 2011. Int J Clin Pharmacol Ther 49, 88–90. Abstract Capecitabine (Cap) combined with bevacizumab (Bev) with or without vinorelbine (Vin) in first-line metastatic breast cancer (MBC): First safety results from the randomized CARIN trial. Hegewisch-Becker, S., Lerchenmüller, C.A., Welt, A., Decker, T., Just, M., Steffens, C., Hipper, A., Marschner, N., 2011. J Clin Oncol (Meeting Abstracts). 2011;29(suppl; abstract 1044). Weiterlesen Age-dependent differences in treatment of patients with Multiple Myeloma and Chronic Lymphocytic Leukaemia in outpatient cancer centres in Germany. Data from a clinical registry – TLN Registry. Knauf, W., Abenhardt, W., Aldaoud, A., Lerchenmüller, C., Koska, M., Marschner, N., 2011. Onkologie 34 (suppl 6)(V118), 21. doi:10.1159/000333299 Abstract… Weiterlesen